Clinical Trials Browser

Unknown × Interventional × Mastocytosis × Clear all

NCT04333108 2023-05-06

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Phase 3 Unknown

140 enrolled

Myeloid

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

NCT03340155 2017-11-13

BioUV2017

Phase NA Unknown

240 enrolled

DermatologicLymphoidMyeloid

Eczema, Graft vs Host Disease, Lichen Planus, Lymphoproliferative Disorders, Mastocytosis, Prurigo, Pruritus, Psoriasis, Vitiligo, Lymphoma, T-Cell, Cutaneous

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Phase 2/3 Unknown

10 enrolled

Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

Phase 2 Unknown

20 enrolled

Myeloid

Mastocytosis, Mastocytosis, Systemic